authors
- Dae Hyun Kim, MD, MPH, ScD
- Ko, Darae
- Singer, Daniel E
- Cervone, Alexander
- Zhang, Yichi
- Chen, Qiaoxi
- Lin, Kueiyu Joshua
Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- August 27, 2025
published in
has subject area
- Administration, Oral
- Aged
- Aged, 80 and over
- Anticoagulants
- Atrial Fibrillation
- Databases, Factual
- Drug Substitution
- Factor Xa Inhibitors
- Female
- Hemorrhage
- Humans
- Ischemic Stroke
- Male
- Medicare
- Pyrazoles
- Pyridones
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Rivaroxaban
- Time Factors
- Treatment Outcome
- United States
- Warfarin